12:00 AM
Feb 14, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Anti-retroviral immunotherapeutics including Remune regulatory update

IMNR received U.S. Patents Nos. 6,017,543 and 5,895,650 covering immune stimulation...

Read the full 33 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >